Tick-Borne Disease Research Program Therapeutic/Diagnostic Research Award
This grant supports early-stage research to develop new treatments or diagnostic tools for Lyme and other tick-borne diseases, aiming to improve patient care and quality of life.
Funder: Dept. of the Army -- USAMRAA
Due Dates: July 22, 2026: Pre-Application (Preproposal) | October 22, 2026: Full Application | October 27, 2026: Application Verification
Funding Amounts: Approx. $2.65M total; up to $1,325,000 total costs per award (max 3 years); ~2 awards expected
Summary: Supports product-driven therapeutic and diagnostic research to reduce the burden of Lyme and other tick-borne diseases and improve patient care.
Key Information: Preliminary data required; clinical trials not allowed; pre-application is mandatory for full application invitation.
Description
This opportunity from the Department of the Army's USAMRAA, through the Tick-Borne Disease Research Program (TBDRP), aims to fund translational research focused on developing therapeutics and diagnostics for Lyme disease and other tick-borne diseases. The award is intended for projects that advance new treatments or diagnostic tools toward clinical use, with the end goal of reducing disease burden and improving quality of life for both military and civilian populations. Emphasis is placed on product-driven research with clear translational potential.
